Health Condition 1: L905- Scar conditions and fibrosis of skin
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with facial atrophic acne scars Patients of age 18 years or more
Exclusion criteria
Exclusion criteria: Patients with history or tendency to develop keloid/hypertrophic scars Patients with active acne Patients who have undergone any skin resurfacing procedure within preceding 1 year Pregnant subjects Active herpes simplex in treatment area Immunocompromised patients Patients with history of bleeding diathesis or coagulation defects Recent (
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of microneedling with 15% TCA and 25% pyruvic acid peels in management of post acne scarringTimepoint: Better improvement in Acne scar severity grading at the end of 21 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess patient satisfaction with microneedling using 15% TCA and 25% pyruvic acid in management of post acne scarringTimepoint: Better patient satisfaction with microneedling using 15% TCA and 25% pyruvic acid in management of acne scar at the end of 21 weeks | — |
Countries
India
Contacts
Delhi university